 | • レポートコード：MRC2012A5403 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、レナリドマイド薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。レナリドマイド薬の種類別市場規模（5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル）、用途別市場規模（多発性骨髄腫（MM）、骨髄異形成症候群（MDS）、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Celgene、Exova、 ・地域別グローバル市場分析 2015年-2020年 ・レナリドマイド薬の北米市場（アメリカ、カナダ、メキシコ） ・レナリドマイド薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・レナリドマイド薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・レナリドマイド薬の南米市場（ブラジル、アルゼンチン） ・レナリドマイド薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル ・用途別分析：多発性骨髄腫（MM）、骨髄異形成症候群（MDS）、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Lenalidomide Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Lenalidomide Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Lenalidomide Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lenalidomide Drug market has been segmented into
5 mg Capsules
10 mg Capsules
15 mg Capsules
25 mg Capsules
By Application, Lenalidomide Drug has been segmented into:
Multiple myeloma (MM)
Myelodysplastic syndromes (MDS)
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lenalidomide Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Lenalidomide Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lenalidomide Drug market.
The report offers in-depth assessment of the growth and other aspects of the Lenalidomide Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Lenalidomide Drug Market Share Analysis
Lenalidomide Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lenalidomide Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lenalidomide Drug sales, revenue and market share for each player covered in this report.
The major players covered in Lenalidomide Drug are:
Celgene
Exova
Among other players domestic and global, Lenalidomide Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lenalidomide Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lenalidomide Drug, with price, sales, revenue and global market share of Lenalidomide Drug in 2018 and 2019.
Chapter 3, the Lenalidomide Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lenalidomide Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Lenalidomide Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Lenalidomide Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Lenalidomide Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lenalidomide Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 5 mg Capsules
1.2.3 10 mg Capsules
1.2.4 15 mg Capsules
1.2.5 25 mg Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Lenalidomide Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Multiple myeloma (MM)
1.3.3 Myelodysplastic syndromes (MDS)
1.3.4 Other
1.4 Overview of Global Lenalidomide Drug Market
1.4.1 Global Lenalidomide Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Celgene
2.1.1 Celgene Details
2.1.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Celgene SWOT Analysis
2.1.4 Celgene Product and Services
2.1.5 Celgene Lenalidomide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Exova
2.2.1 Exova Details
2.2.2 Exova Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Exova SWOT Analysis
2.2.4 Exova Product and Services
2.2.5 Exova Lenalidomide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Lenalidomide Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Lenalidomide Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Lenalidomide Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Lenalidomide Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Lenalidomide Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Lenalidomide Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Lenalidomide Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Lenalidomide Drug Sales and Growth Rate (2015-2020)
4.3 Europe Lenalidomide Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Lenalidomide Drug Sales and Growth Rate (2015-2020)
4.5 South America Lenalidomide Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Lenalidomide Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Lenalidomide Drug Sales, Revenue and Market Share by Country
5.1.1 North America Lenalidomide Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Lenalidomide Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Lenalidomide Drug Sales and Growth Rate (2015-2020)
5.3 Canada Lenalidomide Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Lenalidomide Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Lenalidomide Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Lenalidomide Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Lenalidomide Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Lenalidomide Drug Sales and Growth Rate (2015-2020)
6.3 UK Lenalidomide Drug Sales and Growth Rate (2015-2020)
6.4 France Lenalidomide Drug Sales and Growth Rate (2015-2020)
6.5 Russia Lenalidomide Drug Sales and Growth Rate (2015-2020)
6.6 Italy Lenalidomide Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Lenalidomide Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Lenalidomide Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Lenalidomide Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Lenalidomide Drug Sales and Growth Rate (2015-2020)
7.3 Japan Lenalidomide Drug Sales and Growth Rate (2015-2020)
7.4 Korea Lenalidomide Drug Sales and Growth Rate (2015-2020)
7.5 India Lenalidomide Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Lenalidomide Drug Sales and Growth Rate (2015-2020)
7.7 Australia Lenalidomide Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Lenalidomide Drug Sales, Revenue and Market Share by Country
8.1.1 South America Lenalidomide Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Lenalidomide Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Lenalidomide Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Lenalidomide Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Lenalidomide Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Lenalidomide Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Lenalidomide Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Lenalidomide Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Lenalidomide Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Lenalidomide Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Lenalidomide Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Lenalidomide Drug Sales and Market Share by Type (2015-2020)
10.2 Global Lenalidomide Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Lenalidomide Drug Price by Type (2015-2020)
11 Global Lenalidomide Drug Market Segment by Application
11.1 Global Lenalidomide Drug Sales Market Share by Application (2015-2020)
11.2 Global Lenalidomide Drug Revenue Market Share by Application (2015-2020)
11.3 Global Lenalidomide Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Lenalidomide Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Lenalidomide Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Lenalidomide Drug Market Forecast (2021-2025)
12.2.2 Europe Lenalidomide Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Lenalidomide Drug Market Forecast (2021-2025)
12.2.4 South America Lenalidomide Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Lenalidomide Drug Market Forecast (2021-2025)
12.3 Lenalidomide Drug Market Forecast by Type (2021-2025)
12.3.1 Global Lenalidomide Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Lenalidomide Drug Market Share Forecast by Type (2021-2025)
12.4 Lenalidomide Drug Market Forecast by Application (2021-2025)
12.4.1 Global Lenalidomide Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Lenalidomide Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Lenalidomide Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lenalidomide Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lenalidomide Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Celgene Basic Information, Manufacturing Base and Competitors
Table 8. Celgene Lenalidomide Drug Major Business
Table 9. Celgene Lenalidomide Drug Total Revenue (USD Million) (2017-2018)
Table 10. Celgene SWOT Analysis
Table 11. Celgene Lenalidomide Drug Product and Services
Table 12. Celgene Lenalidomide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Exova Basic Information, Manufacturing Base and Competitors
Table 14. Exova Lenalidomide Drug Major Business
Table 15. Exova Lenalidomide Drug Total Revenue (USD Million) (2017-2018)
Table 16. Exova SWOT Analysis
Table 17. Exova Lenalidomide Drug Product and Services
Table 18. Exova Lenalidomide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Lenalidomide Drug Sales by Manufacturer (2018-2019) (K Units)
Table 20. Global Lenalidomide Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Lenalidomide Drug Sales by Regions (2015-2020) (K Units)
Table 22. Global Lenalidomide Drug Sales Market Share by Regions (2015-2020)
Table 23. Global Lenalidomide Drug Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Lenalidomide Drug Sales by Countries (2015-2020) (K Units)
Table 25. North America Lenalidomide Drug Sales Market Share by Countries (2015-2020)
Table 26. North America Lenalidomide Drug Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Lenalidomide Drug Revenue Market Share by Countries (2015-2020)
Table 28. Europe Lenalidomide Drug Sales by Countries (2015-2020) (K Units)
Table 29. Europe Lenalidomide Drug Sales Market Share by Countries (2015-2020)
Table 30. Europe Lenalidomide Drug Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Lenalidomide Drug Sales by Regions (2015-2020) (K Units)
Table 32. Asia-Pacific Lenalidomide Drug Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Lenalidomide Drug Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Lenalidomide Drug Sales by Countries (2015-2020) (K Units)
Table 35. South America Lenalidomide Drug Sales Market Share by Countries (2015-2020)
Table 36. South America Lenalidomide Drug Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Lenalidomide Drug Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Lenalidomide Drug Sales by Countries (2015-2020) (K Units)
Table 39. Middle East & Africa Lenalidomide Drug Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Lenalidomide Drug Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Lenalidomide Drug Revenue Market Share by Countries (2015-2020)
Table 42. Global Lenalidomide Drug Sales by Type (2015-2020) (K Units)
Table 43. Global Lenalidomide Drug Sales Share by Type (2015-2020)
Table 44. Global Lenalidomide Drug Revenue by Type (2015-2020) (USD Million)
Table 45. Global Lenalidomide Drug Revenue Share by Type (2015-2020)
Table 46. Global Lenalidomide Drug Sales by Application (2015-2020) (K Units)
Table 47. Global Lenalidomide Drug Sales Share by Application (2015-2020)
Table 48. Global Lenalidomide Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 49. Global Lenalidomide Drug Market Share Forecast by Regions (2021-2025)
Table 50. Global Lenalidomide Drug Sales Forecast by Type (2021-2025) (K Units)
Table 51. Global Lenalidomide Drug Market Share Forecast by Type (2021-2025)
Table 52. Global Lenalidomide Drug Sales Forecast by Application (2021-2025)
Table 53. Global Lenalidomide Drug Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Lenalidomide Drug Picture
Figure 2. Global Sales Market Share of Lenalidomide Drug by Type in 2019
Figure 3. 5 mg Capsules Picture
Figure 4. 10 mg Capsules Picture
Figure 5. 15 mg Capsules Picture
Figure 6. 25 mg Capsules Picture
Figure 7. Lenalidomide Drug Sales Market Share by Application in 2018
Figure 8. Multiple myeloma (MM) Picture
Figure 9. Myelodysplastic syndromes (MDS) Picture
Figure 10. Other Picture
Figure 11. Global Lenalidomide Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Lenalidomide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Lenalidomide Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Lenalidomide Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Lenalidomide Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Lenalidomide Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Lenalidomide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Lenalidomide Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Lenalidomide Drug Revenue Market Share by Regions in 2018
Figure 40. North America Lenalidomide Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Lenalidomide Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Lenalidomide Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Lenalidomide Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Lenalidomide Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Lenalidomide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Lenalidomide Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Lenalidomide Drug Sales Market Share by Countries in 2018
Figure 48. North America Lenalidomide Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Lenalidomide Drug Revenue Market Share by Countries in 2018
Figure 50. United States Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Lenalidomide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Lenalidomide Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Lenalidomide Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Lenalidomide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Lenalidomide Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Lenalidomide Drug Revenue Market Share by Regions 2019
Figure 64. China Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Lenalidomide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Lenalidomide Drug Sales Market Share by Countries in 2019
Figure 71. South America Lenalidomide Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Lenalidomide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Lenalidomide Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Lenalidomide Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Lenalidomide Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Lenalidomide Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Lenalidomide Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Lenalidomide Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Lenalidomide Drug Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Lenalidomide Drug Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Lenalidomide Drug Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Lenalidomide Drug Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Lenalidomide Drug Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
樹脂カプセルの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Resin Capsules market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1019.6 million by 2025, from USD 925.8 million in 2019. The Resin Capsules market …- ナップカプセルの世界市場（～2026年） Nap pod is the special chair or cubicle, used to allow people to take nap often at the workstation and or in corporate places. Nap pod is also known as energy pod or nap capsule. Nap pod allows employees to take a short 15-20 minute nap which is in the effective and easy way. Nap pod takes off the p…
- 有機カプセルの世界市場（～2026年） Organic capsule is a kind of capsule, compared to ordinary capsule, it is more natural alternative, starch-free, gluten-free, preservative-free, vegetable origin and non-GMO. Market Analysis and Insights: Global Organic Capsules Market The global Organic Capsules market size is projected to reach US…
- 特殊カプセルの世界市場（～2026年） Specialty Capsule refers to capsule that developed from special kind of raw material. In this report, it can be divided into coffee Capsules, gelatin Capsules Market Analysis and Insights: Global Specialty Capsules Market The global Specialty Capsules market size is projected to reach US$ XX million…
- 液体充填カプセルの世界市場（～2026年） Liquid-filled capsule is the gelatin shell which is for liquid, semi-solid, paste and multiparticulate applications. It has good bioavailability, and can be safely dissolved quickly and reliably. Market Analysis and Insights: Global Liquid-filled Capsules Market The global Liquid-filled Capsules mar…